Care By Design Hemp, a wholly-owned CannaCraft CBD brand, has joined several other leading CBD companies in ValidCare’s IRB-approved safety study to observe the effects of full-spectrum hemp-derived CBD and CBD isolate on the livers of healthy adults. The data will answer the FDA’s call for more scientific data, which will be used to determine the appropriate regulatory paths for hemp-derived CBD products. The other companies participating in this valuable study include Charlotte's Web, Boulder Botanical & Bioscience Labs, CBDistillery, CBD American Shaman, Columbia Care, Global Widget, HempFusion, Kannaway, MedterraCBD, SunFlora, Asterra Lab, and Infinite CBD. ValidCare aims to complete the study, which kicked off in July, by the end of 2020. “There's a real dearth of quality safety data out there as cannabis and CBD have been very challenging to research historically due to federal restrictions,” says Matt Elmes, Ph.D., head of research and development at CannaCraft. “We welcome this unique opportunity to work alongside our consumers to meaningfully advance cannabinoid science. The valuable data we generate together will undoubtedly impact the future of hemp-derived CBD in the USA."
RELATED STORIES
The Lodge at Woodloch Introduces New CBD Treatments
Sacred CBD Partners With Artisan Farmacy to Launch Online Wellness Platform
Simply CBD FL Develops Cooling Muscle Balm for Athletes